EBOS acquires cornerstone shareholding in MedAdvisor

EBOS is pleased to announce that it has made an investment of A$10.5 million to acquire a strategic 14.1% shareholding in Australia’s leading digital medication management company, MedAdvisor Limited (ASX: MDR).

MedAdvisor’s software system has wide customer acceptance with over 900,000 users and is connected to over 2,600 Australian pharmacies.

EBOS' investment is part of a wider partnership with MedAdvisor that will seek to advance the commercial interests of both organisations by increasing the availability of digital health applications across EBOS' community pharmacy and institutional healthcare businesses.